Mobile app and community coaching for managing type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on enhancing diabetes management for patients with type 2 diabetes through a mobile health app called EMPOWER+ and community-based health coaching. The approach emphasizes continuous, personalized support rather than traditional periodic clinical visits, allowing health coaches to work directly with patients to set realistic goals and develop individualized action plans. The app includes features for logging health data, gamification elements for goal setting, educational resources, and personalized nudges based on user inputs. This combination aims to improve self-management skills crucial for managing diabetes effectively.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged 21 years and above
* Having been diagnosed with type 2 diabetes mellitus
* Having most recent HbA1c ≥ 6.5%
* Physically able to exercise
* Able to read, write, and converse in English
* Able to comply with study procedures

Exclusion Criteria:

* Requiring assistance with basic activities of daily living (BADL)
* Have planned major operation or surgical procedure within 6 months from the time of recruitment
* Current pregnant or lactating

Where it's running

• Singapore General Hospital
  Singapore, Singapore Recruiting
• Singapore General Hospital
  Singapore, Singapore Not yet recruiting

Study contacts

• Study coordinator: Research coordinators
• Email: empower@singhealth.com.sg
• Phone: 6562223222

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Proliverenol for liver fat and insulin resistance in type 2 diabetes

  This study tests whether adding Proliverenol to standard diabetes care can improve liver fat and blood sugar control in adults with type 2 diabetes.

  Recruiting Phase 2 Universitas Sriwijaya · Palembang, South Sumatera · NCT07928661

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Safety test of NNC9836-0001 in adults with overweight/obesity or type 2 diabetes

  This study tests whether the new medicine NNC9836-0001 is safe and tolerable in adults who are overweight or have type 2 diabetes, compared to placebo.

  Recruiting Phase 1 Novo Nordisk A/S · Neuss · NCT07896109

• RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes

  This study tests the accuracy and safety of the RIGHTEST iFree 2 continuous glucose monitor in pregnant adults with type 1, type 2, or gestational diabetes.

  Recruiting Bionime Corporation · Ulm, Baden-Wurttemberg · NCT07889388

• EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes

  This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.

  Recruiting Phase 3 Eli Lilly and Company · Tucson, Arizona and 74 other locations · NCT07881458

• Maridebart cafraglutide vs. semaglutide for type 2 diabetes on metformin

  This trial tests whether maridebart cafraglutlide is as good as semaglutide at improving blood sugar in adults with type 2 diabetes who take metformin (with or without an SGLT-2 inhibitor).

  Recruiting at 8 sites Phase 3 Amgen · San Diego, California and 7 other locations · NCT07866066

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.